Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on LinkedIn:
“Tec-Dara vs. CAR T-Cell Therapy: Sequencing BCMA-Directed Therapy in Multiple Myeloma.”
Title: Tec-Dara vs. CAR T-Cell Therapy: Sequencing BCMA-Directed Therapy in Multiple Myeloma
Author: Natalie Rafaeli
Other articles about Multiple Myeloma on OncoDaily.